Postprandial gastrin-17 level is a useful dynamic marker for atrophic gastritis  

作　　者：Huck-Joo Tan Eunice Zhi-Yi Tan 

机构地区：[1]Department of Gastroenterology and Hepatology,Cengild GI Medical Center,Kuala Lumpur 50490,Malaysia [2]Department of Internal Medicine,University Hospital Southampton,Southampton SO166YD,United Kingdom

出　　处：《World Journal of Gastrointestinal Endoscopy》2024年第11期623-626,共4页世界胃肠内镜杂志（英文）

摘　　要：Atrophic gastritis and intestinal metaplasia may progress to gastric malignancy.Non-invasive serum biomarkers have been extensively studied and proven to be useful as a screening tool to stratify risk and identify patients for endoscopy to detect early gastric cancer.These non-invasive biomarkers have been endorsed and recommended by many international consensus guidelines.In this letter,we reviewed the literature and evidence supporting the use of serum biomarkers as a dynamic test to monitor the status of atrophic gastritis.

关 键 词：Atrophic gastritis PEPSINOGEN GASTRIN-17 Gastric cancer Biomarkers 

分 类 号：R573.3[医药卫生—消化系统]